Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects-Reference-Cited by-同舟云学术

Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects

Published:2020-08-03 Issue:9 Volume:20 Page:1033-1046
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Sharun Khan¹^ORCID,Tiwari Ruchi²^ORCID,Iqbal Yatoo Mohd.³^ORCID,Patel Shailesh Kumar⁴,Natesan Senthilkumar⁵,Dhama Jaideep⁶,Malik Yashpal S.⁷^ORCID,Harapan Harapan⁸⁹¹⁰^ORCID,Singh Raj Kumar¹¹,Dhama Kuldeep⁴^ORCID

Affiliation:

1. Division of Surgery, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India

2. Department of Veterinary Microbiology and Immunology, College Of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, Uttar Pradesh, India

3. Division of Veterinary Clinical Complex, Faculty of Veterinary Sciences and Animal Husbandry, Shuhama, Alusteng Srinagar, Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir, Srinagar, Jammu and Kashmir, India

4. Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India

5. Department of Infectious Diseases, Indian Institute of Public Health Gandhinagar, Gandhinagar, Gujarat, India

6. Department of Ophthalmology, Tara Hospital, New Delhi, India

7. Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India

8. Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

9. Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

10. Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

11. Division of Veterinary Biotechnology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India

Funder

Funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1796963

Reference101 articles.

1. Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors

2. WHO. 2020. [cited 2020 May 18]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

3. Coronavirus Disease 2019–COVID-19

4. Coronavirus disease 2019 (COVID-19): A literature review

5. SARS-CoV-2: Jumping the Species Barrier, Lessons from SARS and MERS, Its Zoonotic Spillover, Transmission to Humans, Preventive and Control Measures and Recent Developments to Counter This Pandemic Virus

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19: etiology;Molecular Medical Microbiology;2024

2. Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination;Biomedicines;2023-10-17

3. Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan;Viruses;2023-09-19

4. Determinants of COVID-19 vaccine Hesitancy: 2020 California Health Interview Survey;Preventive Medicine Reports;2023-06

5. COVID-19 Disease Prediction Utilizing Dilated Convolution Neural Network Based Levy Flight Tunicate Swarm Optimization;Wireless Personal Communications;2023-05-27